Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.

Petrov I, Suntsova M, Ilnitskaya E, Roumiantsev S, Sorokin M, Garazha A, Spirin P, Lebedev T, Gaifullin N, Larin S, Kovalchuk O, Konovalov D, Prassolov V, Roumiantsev A, Buzdin A.

Oncotarget. 2017 Jul 28;8(48):83768-83780. doi: 10.18632/oncotarget.19662. eCollection 2017 Oct 13.

2.

Atrial Flutter in the Neonate: A Case Study.

Roumiantsev S, Settle MD.

Neonatal Netw. 2017 Sep 1;36(5):313-317. doi: 10.1891/0730-0832.36.5.313.

PMID:
28847356
3.

PO-59 - Hemorheologic disturbances as thrombosis risk factor in patients with some myeloproliferative neoplasms.

Roitman EV, Kolesnikova IM, Davydkin IL, Kozlova NS, Roumiantsev SA.

Thromb Res. 2016 Apr;140 Suppl 1:S198. doi: 10.1016/S0049-3848(16)30192-X. Epub 2016 Apr 8.

PMID:
27161748
4.

PO-56 - Subsequent clot properties depend on the storage time of platelet concentrates.

Kolesnikova IM, Roitman EV, Karpova OV, Roumiantsev SA.

Thromb Res. 2016 Apr;140 Suppl 1:S197. doi: 10.1016/S0049-3848(16)30189-X. Epub 2016 Apr 8.

PMID:
27161744
5.

The cohesin-associated protein Wapal is required for proper Polycomb-mediated gene silencing.

Stelloh C, Reimer MH, Pulakanti K, Blinka S, Peterson J, Pinello L, Jia S, Roumiantsev S, Hessner MJ, Milanovich S, Yuan GC, Rao S.

Epigenetics Chromatin. 2016 Apr 15;9:14. doi: 10.1186/s13072-016-0063-7. eCollection 2016.

6.

Telemedicine Versus Face-to-Face Evaluations by Respiratory Therapists of Mechanically Ventilated Neonates and Children: A Pilot Study.

Bell RC, Yager PH, Clark ME, Roumiantsev S, Venancio HL, Chipman DW, Kacmarek RM, Noviski NN.

Respir Care. 2016 Feb;61(2):149-54. doi: 10.4187/respcare.04080. Epub 2015 Dec 8.

7.

Activation of homologous recombination DNA repair in human skin fibroblasts continuously exposed to X-ray radiation.

Osipov AN, Grekhova A, Pustovalova M, Ozerov IV, Eremin P, Vorobyeva N, Lazareva N, Pulin A, Zhavoronkov A, Roumiantsev S, Klokov D, Eremin I.

Oncotarget. 2015 Sep 29;6(29):26876-85. doi: 10.18632/oncotarget.4946.

8.

A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation.

Artemov A, Aliper A, Korzinkin M, Lezhnina K, Jellen L, Zhukov N, Roumiantsev S, Gaifullin N, Zhavoronkov A, Borisov N, Buzdin A.

Oncotarget. 2015 Oct 6;6(30):29347-56. doi: 10.18632/oncotarget.5119.

9.

Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs.

Venkova L, Aliper A, Suntsova M, Kholodenko R, Shepelin D, Borisov N, Malakhova G, Vasilov R, Roumiantsev S, Zhavoronkov A, Buzdin A.

Oncotarget. 2015 Sep 29;6(29):27227-38. doi: 10.18632/oncotarget.4507.

10.

Low doses of X-rays induce prolonged and ATM-independent persistence of γH2AX foci in human gingival mesenchymal stem cells.

Osipov AN, Pustovalova M, Grekhova A, Eremin P, Vorobyova N, Pulin A, Zhavoronkov A, Roumiantsev S, Klokov DY, Eremin I.

Oncotarget. 2015 Sep 29;6(29):27275-87. doi: 10.18632/oncotarget.4739.

11.

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 20-2015. A Newborn Girl with Hypotension, Coagulopathy, Anemia, and Hyperbilirubinemia.

Roumiantsev S, Shah U, Westra SJ, Misdraji J.

N Engl J Med. 2015 Jun 25;372(26):2542-53. doi: 10.1056/NEJMcpc1404334. No abstract available.

PMID:
26107055
12.

New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome.

Garazha A, Ivanova A, Suntsova M, Malakhova G, Roumiantsev S, Zhavoronkov A, Buzdin A.

Cell Cycle. 2015;14(9):1476-84. doi: 10.1080/15384101.2015.1022696.

13.

Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.

Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, Zhavoronkov A.

Aging (Albany NY). 2015 Jan;7(1):26-37.

14.

Signaling pathways activation profiles make better markers of cancer than expression of individual genes.

Borisov NM, Terekhanova NV, Aliper AM, Venkova LS, Smirnov PY, Roumiantsev S, Korzinkin MB, Zhavoronkov AA, Buzdin AA.

Oncotarget. 2014 Oct 30;5(20):10198-205.

15.

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.

Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB, Zabolotneva AA, Shegay PV, Sokov DG, Gaifullin NM, Rusakov IG, Aliper AM, Roumiantsev SA, Alekseev BY, Borisov NM, Buzdin AA.

Oncotarget. 2014 Oct 15;5(19):9022-32.

16.

Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer.

Aliper AM, Frieden-Korovkina VP, Buzdin A, Roumiantsev SA, Zhavoronkov A.

Oncotarget. 2014 Nov 30;5(22):11345-53.

17.

A role for G-CSF and GM-CSF in nonmyeloid cancers.

Aliper AM, Frieden-Korovkina VP, Buzdin A, Roumiantsev SA, Zhavoronkov A.

Cancer Med. 2014 Aug;3(4):737-46. doi: 10.1002/cam4.239. Epub 2014 Apr 2. Review.

18.

The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis.

Buzdin AA, Zhavoronkov AA, Korzinkin MB, Roumiantsev SA, Aliper AM, Venkova LS, Smirnov PY, Borisov NM.

Front Mol Biosci. 2014 Aug 26;1:8. doi: 10.3389/fmolb.2014.00008. eCollection 2014.

19.

A systematic experimental evaluation of microRNA markers of human bladder cancer.

Zabolotneva AA, Zhavoronkov AA, Shegay PV, Gaifullin NM, Alekseev BY, Roumiantsev SA, Garazha AV, Kovalchuk O, Aravin A, Buzdin AA.

Front Genet. 2013 Nov 15;4:247. doi: 10.3389/fgene.2013.00247. eCollection 2013.

20.

Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

Suntsova M, Gogvadze EV, Salozhin S, Gaifullin N, Eroshkin F, Dmitriev SE, Martynova N, Kulikov K, Malakhova G, Tukhbatova G, Bolshakov AP, Ghilarov D, Garazha A, Aliper A, Cantor CR, Solokhin Y, Roumiantsev S, Balaban P, Zhavoronkov A, Buzdin A.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19472-7. doi: 10.1073/pnas.1318172110. Epub 2013 Nov 11.

21.

Characteristic patterns of microRNA expression in human bladder cancer.

Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA.

Front Genet. 2013 Jan 4;3:310. doi: 10.3389/fgene.2012.00310. eCollection 2012.

22.

Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations.

Nepomnyashchaya YN, Artemov AV, Roumiantsev SA, Roumyantsev AG, Zhavoronkov A.

Clin Chem Lab Med. 2013 Jun;51(6):1141-54. Review.

PMID:
23023923
23.

Differential roles of Sall4 isoforms in embryonic stem cell pluripotency.

Rao S, Zhen S, Roumiantsev S, McDonald LT, Yuan GC, Orkin SH.

Mol Cell Biol. 2010 Nov;30(22):5364-80. doi: 10.1128/MCB.00419-10. Epub 2010 Sep 13.

24.

Non-Markovian Population Dynamics: Does it Help to Optimize the Chemotherapeutic Strategy?

Kuznetsov DA, Roumiantsev SA, Fallahi M, Amirshahi N, Makarov AV, Kardashova KS.

Int J Biomed Sci. 2010 Mar;6(1):71-6.

25.

A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase.

Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van Etten RA.

Mol Cell Biol. 2004 Jun;24(11):4685-95.

26.

Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.

Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, Cross NC, Van Etten RA.

Cancer Cell. 2004 Mar;5(3):287-98.

27.

Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop.

Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL, Van Etten RA.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10700-5. Epub 2002 Jul 29.

28.

Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.

Brasher BB, Roumiantsev S, Van Etten RA.

Oncogene. 2001 Nov 22;20(53):7744-52.

Supplemental Content

Loading ...
Support Center